Tate & Lyle (TATYY) Stock Rating Lowered by Zacks Investment Research

Tate & Lyle (OTCMKTS:TATYY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Friday, February 16th.

According to Zacks, “Tate & Lyle Ventures and Agri Investment Fund have co-led a 3.5m investment into Fugeia, a newly formed functional food technology business with a focus on gut health. “

Several other analysts have also issued reports on TATYY. Kepler Capital Markets upgraded shares of Tate & Lyle from a “hold” rating to a “buy” rating in a research report on Tuesday, February 13th. Societe Generale raised shares of Tate & Lyle from a “hold” rating to a “buy” rating in a report on Friday, February 9th. ValuEngine upgraded shares of Tate & Lyle from a “hold” rating to a “buy” rating in a report on Friday, December 1st. Finally, Jefferies Group upgraded shares of Tate & Lyle from a “hold” rating to a “buy” rating in a report on Monday, October 23rd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $42.00.

Tate & Lyle (OTCMKTS TATYY) traded down $0.17 during trading on Friday, hitting $30.21. 16,691 shares of the stock traded hands, compared to its average volume of 6,639. The company has a market capitalization of $3,530.00, a PE ratio of 10.21, a PEG ratio of 6.24 and a beta of 0.39. Tate & Lyle has a twelve month low of $30.17 and a twelve month high of $42.20.

COPYRIGHT VIOLATION WARNING: “Tate & Lyle (TATYY) Stock Rating Lowered by Zacks Investment Research” was originally published by Equities Focus and is the property of of Equities Focus. If you are reading this news story on another publication, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be accessed at https://www.equitiesfocus.com/2018/03/14/tate-lyle-tatyy-lowered-to-sell-at-zacks-investment-research.html.

About Tate & Lyle

Tate & Lyle PLC is a provider of ingredients and solutions to the food, beverage and other industries. The Company’s segments include Speciality Food Ingredients and Bulk Ingredients. The Speciality Food Ingredients segment’s product categories include dairy, beverage, bakery and convenience. The Bulk Ingredients segment’s product lines include bulk sweeteners for food and beverage customers, and industrial starches for paper and construction industries.

Get a free copy of the Zacks research report on Tate & Lyle (TATYY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Tate & Lyle (OTCMKTS:TATYY)

Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply